PRKCB and atherosclerosis: Furthermore, diabetes-induced activation of protein kinase-β (PKC-β) increases production of AGE from the polyol pathway and leads to accelerated atherosclerosis, reduced insulin-stimulated eNOS production and increased expression of the vasoconstrictive molecule, ET-1 [52,53].